Skip to content

Virtual Reality vs Standard-of-Care for Comfort During Intravenous Catheterization

A Pragmatic Randomized Controlled Trial of Virtual Reality vs Standard-of-Care for Comfort During Intravenous Catheterization

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03681730
Enrollment
64
Registered
2018-09-24
Start date
2018-05-02
Completion date
2019-05-01
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intravenous Catheterization

Keywords

Virtual Reality, Pain, Anxiety

Brief summary

Children often need an intravenous catheter placement for delivery of fluids and medications, a procedure associated with pain and anxiety. In the Emergency Department topical anesthetics are frequently used. Virtual Reality (VR) is an immersive experience using sight, sound, and position sense. Using VR may enhance distraction during the painful procedure and may reduce attention to pain. This study will randomize children (6 - 16 years old) to receive Virtual Reality or standard of care in addition to topical anaesthetics during IV placement procedure. Investigators will measure pain, anxiety and satisfaction, amount of analgesics used and the level of success in placing the IV and compare between the two groups.

Interventions

DEVICEVirtual Reality

Participants wear a Virtual Reality headset that consists of a ASUS phone and a VOX+ Z3 3D Virtual Reality Headset. The phone runs the VR Roller Coaster app to produce the virtual environment.

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Children age 6 - \<17 * The managing physician determines a need for an intravenous catheterization (IV) procedure * Parents will sign a consent form and children will sign an assent form

Exclusion criteria

* Children with conditions that may prohibit participation or evaluation of the procedure (such as developmental delay, autism, others) * Triage Category 1 (resuscitation) * Facial features or injury prohibiting wearing the VR goggles

Design outcomes

Primary

MeasureTime frameDescription
Pain using the Faces Pain Scale - Revised.Pain is reported by children immediately following completion of the IV startLevel of pain as reported by children using Faces Pain Scale - Revised. The scale includes six faces that represent progressively more intense features of pain. Children point to the face that best represents their current level of pain. The minimum score is 0 (representing least pain) and the maximum score is 10 (representing greater pain). The scale increase in increments of 2.

Secondary

MeasureTime frameDescription
Patient Satisfaction determined by Global Rating ScaleSatisfaction questions are reported by children immediately following completion of the IV startSatisfaction from the procedure is determined by asking 4 questions on a global rating scale. This scale goes from 0-10 where 0 represents not very much and 10 represents very much. Questions are developed from previous virtual reality research. Overall, how satisfied are you with pain management during plastic surgery? Overall, how satisfied are you with anxiety management during plastic surgery? To what extent did you feel like you went into the virtual world? How much fun did you have while playing in the virtual world? These questions will be analyzed individually not summed.
Patient Satisfaction determined qualitatively by an open ended questionSatisfaction questions are reported by children immediately following completion of the IV startSatisfaction from the procedure is determined qualitatively. Children are asked What is your opinion on how the procedure went? Answers will be recorded in writing and be assessed for themes (similar words, positive or negative language).
Parent Satisfaction determined qualitatively by an open ended questionSatisfaction question is reported by parents immediately following completion of the IV startSatisfaction from the procedure is determined qualitatively. Parents are asked What is your opinion on how the procedure went? Answers will be recorded in writing and be assessed for themes (similar words, positive or negative language).
Anxiety using the Venham Situational Anxiety ScoreAnxiety is reported by children immediately following completion of the IV startLevel of Situational Anxiety as reported by children using the Venham Situational Anxiety Score. This scale includes 8 sets of 2 images of children which represent differing levels of anxiety. Children point to the child that best represents them in that instance. In each set of 2 images of children, one represents greater anxiety (scored as 1) and one represents lesser anxiety (scored as 0). The points from each set of images are totaled. The minimum score is 0 (least anxious) and maximum score is 8 (most anxious).
Number of IV Trials Until SuccessThis number will be collected during the procedureHow many attempts the nurses need to get a functional IV catheter (concealed objective to avoid a Hawthorne effect).
TimingDocumented immediately after patient and family given discharge paperworkTime in minutes from readiness for procedure (availability of child, staff and equipment) until completion of procedure (nurse does not need to touch the patient anymore) and until discharged from the emergency department (given discharge paperwork).
Medication DoseThese will be recorded during the procedure and immediately following the procedure using the patient chart and nursing notesHow much topical or local anesthetics are used and when they are used (24 hour time); how much sedatives are used and when they are used (24 hour time); how much analgesics are used and when they are used (24 hour time).

Countries

Canada

Contacts

Primary ContactRan D Goldman, MD
rgoldman@cw.bc.ca604-875-2345

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026